CereGate sits in the emerging “software layer for implants” category, augmenting existing neuromodulation devices with communication and adaptive control capabilities rather than developing hardware itself. This platform approach allows it to piggyback on installed DBS infrastructure, though it is dependent on partnerships with device manufacturers for scale.